Scientists grow Cancer-Fighting cells in lab for rare skin cancer
NCT ID NCT06780475
Summary
This early-stage study aims to test a new cell therapy approach for Merkel cell carcinoma, a rare and aggressive skin cancer. Researchers will grow immune cells in a lab that target a virus linked to this cancer, then test how well these cells work. The study involves 15 adult patients with this specific type of cancer to validate if this laboratory method could lead to future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MERKEL CELL CARCINOMA OF SKIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Dermato-oncology Department, Ambroise Paré Hospital, APHP
RECRUITINGBoulogne-Billancourt, 92100, France
Conditions
Explore the condition pages connected to this study.